BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 6714450)

  • 1. Danazol binding to steroid receptors in human uterine endometrium.
    Tamaya T; Wada K; Fujimoto J; Yamada T; Okada H
    Fertil Steril; 1984 May; 41(5):732-5. PubMed ID: 6714450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of human endometrial and myometrial steroid receptors with danazol.
    Jenkin G; Cookson CI; Thorburn GD
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):377-88. PubMed ID: 6627694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a possible direct action of Danazol on the human ovary.
    Milwidsky A; Besch NF; Besch PK; Kaufman RH
    Acta Obstet Gynecol Scand; 1983; 62(2):187-90. PubMed ID: 6868971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Danazol has progestin-like actions on the human endometrium.
    Kokko E; Jänne O; Kauppila A; Rönnberg L; Vihko R
    Acta Endocrinol (Copenh); 1982 Apr; 99(4):588-93. PubMed ID: 6461996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Danazol binding to rat androgen, glucocorticoid, progesterone, and estrogen receptors: correlation with biologic activity.
    Barbieri RL; Lee H; Ryan KJ
    Fertil Steril; 1979 Feb; 31(2):182-6. PubMed ID: 761680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiestrogenic effects of danazol on rabbit uterus.
    Yamashita S; Ohno Y; Watanabe Y; Fujimoto Y; Koishi K; Kawashima M; Hosokawa K; Okada H
    Gynecol Obstet Invest; 1994; 38(4):245-8. PubMed ID: 7851809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestrinone (R2323) binding to steroid receptors in human uterine endometrial cytosol.
    Tamaya T; Fujimoto J; Watanabe Y; Arahori K; Okada H
    Acta Obstet Gynecol Scand; 1986; 65(5):439-41. PubMed ID: 3490730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
    Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
    Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Danazol binding and translocation of steroid receptors.
    Chamness GC; Asch RH; Pauerstein CJ
    Am J Obstet Gynecol; 1980 Feb; 136(4):426-9. PubMed ID: 7355922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro.
    Ikegami H; Terakawa N; Shimizu I; Kano H; Tanaka Y; Aono T; Tanizawa O; Matsumoto K
    Am J Obstet Gynecol; 1986 Oct; 155(4):857-61. PubMed ID: 3766641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium.
    Bayard F; Damilano S; Robel P; Baulieu EE
    J Clin Endocrinol Metab; 1978 Apr; 46(4):635-48. PubMed ID: 755048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition by danazol in a human endometrial cancer cell line with estrogen-independent progesterone receptors.
    Terakawa N; Ikegami H; Shimizu I; Aono T; Tanizawa O; Matsumoto K
    J Steroid Biochem; 1987 Nov; 28(5):571-4. PubMed ID: 3682823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum hormone and steroid hormone receptor levels during luteal-phase and long-term treatment with danazol.
    Tamaya T; Murakami T; Yamada T; Wada K; Fujimoto J; Okada H
    Fertil Steril; 1983 Nov; 40(5):585-9. PubMed ID: 6414847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogenic and progestational activity of 7alpha-methyl-19-nortestosterone, a synthetic androgen.
    Beri R; Kumar N; Savage T; Benalcazar L; Sundaram K
    J Steroid Biochem Mol Biol; 1998 Nov; 67(3):275-83. PubMed ID: 9879986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of morphological changes and steroid receptors in the uteri of postmenopausal women.
    Teresiński L; Sipak O; Rył A; Masiuk M; Rotter I; Ratajczak W; Łazowska M; Słomczyńska M; Marchlewicz M; Karakiewicz B; Kram A; Laszczyńska M
    Histol Histopathol; 2019 Jun; 34(6):631-644. PubMed ID: 30426467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danazol: endocrine pharmacology and therapeutic applications.
    Barbieri RL; Ryan KJ
    Am J Obstet Gynecol; 1981 Oct; 141(4):453-63. PubMed ID: 7025640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
    Phillips A; Hahn DW; McGuire JL
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1191-6. PubMed ID: 1415445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.